Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem
Examining the Truvada #BreakThePatent Debate: Gilead Responds
Why Abbvie May Have A Tough Time Defending Humira’s Price Before Congress
It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment
World’s best-selling drug costs five times more in U.S. than Europe
This billionaire couple is taking on Big Pharma to lower your prescription drug prices
How Big Pharma secures drug monopolies
Public Participation in the Patent System Will Lower Drug Costs
How High-Priced Drugs Cripple Prison Health Care—and Reform
1
2